Tendon Pain That Won't Heal: Beyond Physiotherapy

Tendons are among the slowest-healing structures in the human body. Understanding why requires appreciating their unique biology:

Limited blood supply: Tendons receive far less blood flow than muscles. Blood delivers oxygen, nutrients, and immune cells essential for healing. Some tendons — particularly the mid-portion of the Achilles and the supraspinatus in the shoulder — have watershed zones with especially poor vascularity.

Low cellularity: Tendons contain relatively few cells (tenocytes) embedded in a dense extracellular matrix of collagen fibres. Fewer cells means slower tissue remodelling and repair.

High mechanical demand: Unlike a broken bone that can be immobilised, most tendons remain under load during daily activities. Complete rest is often impractical, and early loading is actually necessary for proper healing — creating a delicate balance.

Collagen turnover is slow: The half-life of tendon collagen is measured in months to years. Replacing damaged collagen with properly organised new tissue takes far longer than healing a muscle strain or skin wound.

Degeneration, not inflammation: Chronic tendinopathy is characterised by failed healing and tissue degeneration rather than active inflammation. This is why anti-inflammatory medications (ibuprofen, corticosteroid injections) often provide only temporary relief — they target a process that is not the primary driver of chronic tendon pain.

Tendinopathy is the umbrella term for tendon pain and dysfunction. It affects an estimated 30% of all musculoskeletal consultations in general practice. Common sites include the Achilles tendon, patellar tendon, rotator cuff, and lateral elbow (tennis elbow).

What standard treatment involves: - Progressive loading exercises (eccentric and heavy slow resistance) - Activity modification - Manual therapy - Shockwave therapy (ESWT) - GTN patches (for some tendinopathies)

Why it sometimes fails: Evidence-based physiotherapy helps the majority of tendinopathy patients, but a significant minority — estimated at 20–30% — do not achieve satisfactory outcomes with conservative management alone. Factors that predict treatment resistance include:

• •Duration of symptoms greater than 3 months before treatment begins
• •Previous corticosteroid injections (which may worsen long-term tendon health)
• •High tendon load demands (athletes, manual workers)
• •Systemic factors: diabetes, obesity, thyroid dysfunction, menopause, and fluoroquinolone antibiotic use all impair tendon healing
• •Significant structural changes (tears, calcification) visible on ultrasound or MRI
• •Psychosocial factors: pain catastrophising, fear-avoidance behaviours, and poor self-efficacy

If you have been doing progressive loading exercises consistently for 12+ weeks without meaningful improvement, it is reasonable to explore additional options with your clinician.

Several newer treatments are available or under investigation for resistant tendinopathy:

Platelet-Rich Plasma (PRP) injections: PRP involves concentrating growth factors from your own blood and injecting them into the damaged tendon. Evidence is mixed — some studies show benefit for specific tendinopathies (notably lateral elbow tendinopathy), while others show no advantage over placebo. NICE does not currently recommend PRP for tendinopathy due to insufficient evidence, though it is available privately.

High-volume injection (HVI): A large volume of saline (with or without corticosteroid) is injected around the tendon to disrupt neovascularisation — the abnormal blood vessel and nerve growth associated with chronic tendinopathy. Evidence is emerging for Achilles and patellar tendinopathy.

Tendon fenestration and percutaneous needle tenotomy: Using ultrasound guidance, a needle is used to repeatedly puncture the degenerated area, stimulating a fresh healing response. Available in some NHS and private musculoskeletal services.

Shockwave therapy (ESWT): Extracorporeal shockwave therapy delivers acoustic energy to the tendon, stimulating cellular repair processes. NICE recommends it for some tendinopathies. Response rates are approximately 60–70%.

Surgical intervention: For truly recalcitrant cases (typically after 6+ months of failed conservative management), surgery to debride degenerated tissue or repair structural tears may be considered. This is usually a last resort.

Several peptides have attracted significant research interest for their potential effects on tendon repair. It is important to note that this research is largely preclinical (animal studies), and none of these peptides are approved medicines for tendinopathy in the UK:

BPC-157 (Body Protection Compound-157): The most widely studied peptide in the context of tendon healing. Multiple rodent studies have shown accelerated healing of transected Achilles tendons, improved collagen organisation, and enhanced biomechanical properties. BPC-157 appears to act through multiple mechanisms including upregulation of growth hormone receptors, stimulation of nitric oxide production, and modulation of growth factor expression.

TB-500 (Thymosin Beta-4): A 43-amino-acid peptide involved in cell migration, angiogenesis, and tissue repair. Animal studies have demonstrated accelerated wound healing and improved outcomes in tendon injury models. TB-500 promotes actin polymerisation, which is essential for cell movement into damaged areas.

GHK-Cu (copper peptide): While better known for skin applications, GHK-Cu has shown effects on extracellular matrix remodelling, collagen synthesis, and anti-inflammatory activity that are theoretically relevant to tendon repair. Animal research is limited but promising.

What the evidence does NOT support: Claims that these peptides are "proven" to heal human tendinopathies. No randomised controlled trials in humans have been completed for any of these peptides in tendon indications. Anecdotal reports, while numerous, are subject to placebo effects, natural healing, and reporting bias.

Any consideration of research peptides for tendon injury should involve a qualified medical professional who can weigh risks, benefits, and alternatives.

Consider seeking specialist assessment (sports medicine physician, orthopaedic consultant, or musculoskeletal specialist) if:

• •Conservative treatment has been applied consistently for 12+ weeks without meaningful improvement
• •Pain is worsening despite appropriate management
• •There is significant functional limitation affecting work or daily activities
• •You suspect a tendon tear (sudden onset of pain, weakness, visible deformity)
• •You have systemic risk factors for poor tendon health (diabetes, thyroid disease, autoimmune conditions)

NHS pathway: Ask your GP for a referral to the musculoskeletal (MSK) service. Most areas have community MSK services that provide specialist physiotherapy, diagnostic imaging, and injection therapies. If these are insufficient, onward referral to orthopaedics or sports medicine is available.

What to expect: The specialist will likely arrange an ultrasound scan to assess tendon structure, review your loading programme, consider injection therapies, and discuss further options if needed.

What to bring to your appointment: A summary of what treatments you have tried, for how long, and with what results. This saves time and helps the specialist tailor their recommendations.

*This article is for educational purposes only and does not constitute medical advice. Persistent tendon pain should be assessed by a qualified healthcare professional.*